MESO Competitors & Alternatives
Compare Mesoblast Ltd with similar stocks in the same industry
Biotechnology
MESO
Main Stock$15.58
Tradestie Score
47
Market Cap
$2.08B
Revenue Growth
15.3%
Analyst Upside
+124.7%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$19.42
|
$2.18B | - | 57 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$20.63
|
$2.02B | - | 54 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$12.42
|
$2.01B | - | 53 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$35.87
|
$1.97B | - | 62 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$9.17
|
$1.92B | - | 60 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$118.50
|
$1.92B | - | 61 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$37.93
|
$1.90B | - | 54 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$36.25
|
$1.84B | - | 45 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$27.69
|
$1.81B | - | 55 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$3.91
|
$1.78B | - | 57 | Compare |
More MESO Analysis
Data updated: Apr 29, 2026 | Industry: Biotechnology (SIC 2836)
226 stocks in this industry